Nutrien Ltd. (NYSE:NTR) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 7.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 775,568 shares of the company's stock after selling 62,437 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.16% of Nutrien worth $37,274,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the company. Bank of Montreal Can boosted its stake in shares of Nutrien by 15.5% during the 2nd quarter. Bank of Montreal Can now owns 13,354,385 shares of the company's stock worth $719,668,000 after acquiring an additional 1,794,333 shares in the last quarter. Silchester International Investors LLP boosted its stake in shares of Nutrien by 164.4% during the 3rd quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company's stock worth $513,437,000 after acquiring an additional 6,642,075 shares in the last quarter. 1832 Asset Management L.P. boosted its stake in shares of Nutrien by 1.9% during the 2nd quarter. 1832 Asset Management L.P. now owns 9,006,528 shares of the company's stock worth $458,522,000 after acquiring an additional 167,312 shares in the last quarter. Altshuler Shaham Ltd boosted its stake in shares of Nutrien by 8.1% during the 2nd quarter. Altshuler Shaham Ltd now owns 5,990,374 shares of the company's stock worth $304,970,000 after acquiring an additional 446,340 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Nutrien by 8.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 5,145,375 shares of the company's stock worth $261,985,000 after acquiring an additional 399,348 shares in the last quarter. Hedge funds and other institutional investors own 63.10% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently commented on NTR. Mizuho decreased their price target on Nutrien from $55.00 to $52.00 and set a "neutral" rating on the stock in a research note on Thursday, August 8th. UBS Group lowered Nutrien from a "buy" rating to a "neutral" rating and reduced their target price for the company from $66.00 to $51.00 in a research note on Thursday, October 10th. Barclays reduced their target price on Nutrien from $68.00 to $55.00 and set an "overweight" rating on the stock in a research note on Friday, August 16th. The Goldman Sachs Group lowered Nutrien from a "buy" rating to a "neutral" rating and reduced their target price for the company from $69.00 to $53.00 in a research note on Tuesday, September 10th. Finally, TD Securities reduced their target price on Nutrien from $63.00 to $61.00 and set a "buy" rating on the stock in a research note on Tuesday, November 12th. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $60.06.

Nutrien Trading Down 1.6 %

NTR traded down $0.76 during trading on Wednesday, hitting $48.02. The company's stock had a trading volume of 1,083,403 shares, compared to its average volume of 1,959,058. The stock has a market cap of $23.72 billion, a PE ratio of 32.38, a PEG ratio of 1.68 and a beta of 0.80. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The firm's 50 day moving average price is $47.96 and its 200-day moving average price is $49.58. Nutrien Ltd. has a twelve month low of $44.65 and a twelve month high of $60.87.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing analysts' consensus estimates of $0.43 by ($0.04). The firm had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The company's quarterly revenue was down 5.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.35 earnings per share. On average, analysts expect that Nutrien Ltd. will post 3.56 earnings per share for the current year.

Nutrien Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 17th. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.939 per share. This represents a $3.76 dividend on an annualized basis and a dividend yield of 7.82%. This is an increase from Nutrien's previous quarterly dividend of $0.54. The ex-dividend date of this dividend is Tuesday, December 31st. Nutrien's dividend payout ratio is presently 144.97%.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.